AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Pluri Inc. Director's Dealing 2019

Mar 18, 2019

6990_dirs_2019-03-18_e03c80c4-d5b4-4a10-be2f-503b34ee5b8d.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: PLURISTEM THERAPEUTICS INC (PSTI)
CIK: 0001158780
Period of Report: 2019-03-17

Reporting Person: Franco-Yehuda Chen (Chief Financial Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	77158	Direct

Footnotes

F1: Includes 43,000 shares issuable upon vesting of Restricted Stock Units on various dates ranging from June 30, 2019 to December 31, 2022.